AfoliOpen Afoli →

Tetrabenazine

Tetrabenazine is an approved active ingredient.

Open in Afoli Medicines →

Chemical compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

Boxed warning (US label)

Depression and suicidality. DEPRESSION AND SUICIDALITY XENAZINE can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease.

What it is used for

XENAZINE is indicated for the treatment of chorea associated with Huntington’s disease. XENAZINE is a vesicular monoamine transporter 2 (VMAT) inhibitor indicated for the treatment of chorea associated with Huntington’s disease.

US label

Treatment of moderate to severe tardive dyskinesia in adults.

EMA

How it works

Common side effects

The following serious adverse reactions are described below and elsewhere in the labeling: • Depression and Suicidality • Neuroleptic Malignant Syndrome (NMS) • Akathisia, Restlessness, and Agitation • Parkinsonism • Sedation and Somnolence • QTc Prolongation • Hypotension and Orthostatic Hypotension •…

US label

Who should not take it

XENAZINE is contraindicated in patients: • Who are actively suicidal, or in patients with untreated or inadequately treated depression. • With hepatic impairment. • Taking monoamine oxidase inhibitors (MAOIs).

US label

Pregnancy and breastfeeding

There are no adequate data on the developmental risk associated with the use of XENAZINE in pregnant women. Administration of tetrabenazine to rats throughout pregnancy and lactation resulted in an increase in stillbirths and postnatal offspring mortality.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Austedo · Austedo XR · Xenazine

European Union

Austedo

Canada

Apo-Tetrabenazine · Nitoman · Pms-Tetrabenazine

Other trade names

Revocon · Tetmodis · Xenazine 25

Approval status

US Food and Drug Administration
prescription · since 2008
European Medicines Agency
authorised · since 2026
Health Canada
prescription · marketed
First approval anywhere
2008

Codes

ATC
N07XX06, N07XX16
RxNorm CUI
10390
ChEMBL
CHEMBL117785
PubChem CID
6018
UNII
Z9O08YRN8O
Wikidata
Q413050

Frequently asked questions

What is Tetrabenazine used for?

Tetrabenazine is used for: Tardive dyskinesia, Huntington's disease, Tourette syndrome, Choreic movement, Congenital torticollis, and Choreatic disease.

What are the brand names of Tetrabenazine?

Brand names of Tetrabenazine include Austedo, Austedo XR, Xenazine, Apo-Tetrabenazine, Nitoman, Pms-Tetrabenazine, Revocon, and Tetmodis.

Medicines in the same class

Sources and licences

Updated November 15, 2026